Export Administration Regulations
- All
- News
-
Nvidia Says US Advanced Timeline for Export Curbs of AI Chips to China, Other Countries
Chip designer Nvidia said new US export curbs that block the sale of its high-end artificial intelligence chips to China came into effect on Monday as regulators advanced the timeline. The restrictions were supposed to come into play 30 days from October 17 when the Biden administration unveiled measures to stop countries, including China, Iran and...
-
US Chipmaker Micron's Products to Be Examined in China for Cybersecurity Risks
China's cyberspace regulator will conduct a cybersecurity review of products sold in the country by US memory chip manufacturer Micron Technology, the regulator said on Friday. The move, which comes amid a spat over chip technology between Washington and Beijing, is aimed at protecting the security of the supply chain for critical information infr...
-
US Set to Widen Curbs on Semiconductors for AI, Chipmaking Tools Shipments to China: Report
The Biden administration reportedly plans to broaden the curbs on the US shipments of semiconductors used for artificial intelligence and chipmaking tools to China. Based on the restrictions that were communicated in letters to three US companies, the US Commerce Department intends to publish new regulations to restrict to shipments of the chips, a...
-
China Announces Mandatory Security Reviews for Companies’ Data Exports From September 1
The Cyberspace Administration of China (CAC) said on Thursday that a new regulatory framework that will affect several Chinese companies will go into effect on September 1. The cyberspace regulator will enforce a compulsory security review that will determine whether large quantities of Chinese user data in the possession of a private entity can be...
-
Blue Origin Has No Safety Issues, Says US Aviation Regulator After Investigation
US Federal Aviation Administration (FAA) investigating allegations made against Blue Origin’s human spaceflight program said it found no safety issues.
-
US Puts Sanctions On 7 Pak Firms Associated With Country's Missile Programme
The US has slapped sanctions on seven Pakistani entities associated with the country's missile programme, a media report said today.
-
Wockhardt Gets Inspection Report With Observations From US Regulator
Drug firm Wockhardt on Thursday said the US Food and Drug Administration (FDA) has made "observations" in its Establishment Inspection Report (EIR) for the company's three units in Maharashtra and a ban on exports from the facilities to the US will continue.
-
US Regulator's Actions Hurting Exports: Dr Reddy's
Asserting that regulatory action by the US Food and Drug Administration (FDA) on leading Indian firms has impacted exports from the country, Dr Reddy's Laboratories chairman Satish Reddy on Wednesday asked for a dialogue between government and US health regulator.
-
Barack Obama Administration Loosens Cuba Embargo With New Measures
The Obama administration is loosening the US trade embargo on Cuba with a new round of regulations allowing American companies to sell to Cuba on credit and export a potentially wide range of products to the Cuban government for the first time, officials said yesterday.
-
US Regulator Issues Import Alert on Aarti Drugs' 2 Plants
Aarti Drugs on Tuesday said its two manufacturing facilities have received import alert from the US Food and Drug Administration, a development which could impact the company's exports to the American market.
-
US Regulator Raises Concerns on Waluj Plant: Wockhardt
Shares in Wockhardt Ltd fell as much as 5.3 per cent on Thursday after the drug maker said the US Food and Drug Administration (FDA) had raised fresh concerns about a plant already banned from exporting to the United States over quality issues.
-
Wockhardt Says US Drug Regulator Raises Concern Over US Unit
The FDA last year banned Wockhardt's two Indian units from exporting to the United States, its biggest market, citing quality lapses in the manufacturing process.
-
Pharma Exports to US to Remain Unaffected by Import Alerts: India Ratings
Indian pharmaceutical exports to the US are expected to keep growing despite a spate of import alerts issued by the American drug regulator in 2013, according to a report by India Ratings & Research.
-
India Acts to Repair Reputation as Drugs Exporter
As part of the charm offensive, New Delhi has invited global regulators - including the FDA - to visit Indian production units to get first-hand evidence of measures taken to ensure the quality of locally manufactured generics.
-
Ranbaxy shares slump; US regulator raises concerns about India plants
All of Ranbaxy's India-based factories are currently banned by the FDA from exporting medicines to the United States, the company's largest market, after the regulator's inspection found violation of its so-called good manufacturing practices.
-
Nvidia Says US Advanced Timeline for Export Curbs of AI Chips to China, Other Countries
Chip designer Nvidia said new US export curbs that block the sale of its high-end artificial intelligence chips to China came into effect on Monday as regulators advanced the timeline. The restrictions were supposed to come into play 30 days from October 17 when the Biden administration unveiled measures to stop countries, including China, Iran and...
-
US Chipmaker Micron's Products to Be Examined in China for Cybersecurity Risks
China's cyberspace regulator will conduct a cybersecurity review of products sold in the country by US memory chip manufacturer Micron Technology, the regulator said on Friday. The move, which comes amid a spat over chip technology between Washington and Beijing, is aimed at protecting the security of the supply chain for critical information infr...
-
US Set to Widen Curbs on Semiconductors for AI, Chipmaking Tools Shipments to China: Report
The Biden administration reportedly plans to broaden the curbs on the US shipments of semiconductors used for artificial intelligence and chipmaking tools to China. Based on the restrictions that were communicated in letters to three US companies, the US Commerce Department intends to publish new regulations to restrict to shipments of the chips, a...
-
China Announces Mandatory Security Reviews for Companies’ Data Exports From September 1
The Cyberspace Administration of China (CAC) said on Thursday that a new regulatory framework that will affect several Chinese companies will go into effect on September 1. The cyberspace regulator will enforce a compulsory security review that will determine whether large quantities of Chinese user data in the possession of a private entity can be...
-
Blue Origin Has No Safety Issues, Says US Aviation Regulator After Investigation
US Federal Aviation Administration (FAA) investigating allegations made against Blue Origin’s human spaceflight program said it found no safety issues.
-
US Puts Sanctions On 7 Pak Firms Associated With Country's Missile Programme
The US has slapped sanctions on seven Pakistani entities associated with the country's missile programme, a media report said today.
-
Wockhardt Gets Inspection Report With Observations From US Regulator
Drug firm Wockhardt on Thursday said the US Food and Drug Administration (FDA) has made "observations" in its Establishment Inspection Report (EIR) for the company's three units in Maharashtra and a ban on exports from the facilities to the US will continue.
-
US Regulator's Actions Hurting Exports: Dr Reddy's
Asserting that regulatory action by the US Food and Drug Administration (FDA) on leading Indian firms has impacted exports from the country, Dr Reddy's Laboratories chairman Satish Reddy on Wednesday asked for a dialogue between government and US health regulator.
-
Barack Obama Administration Loosens Cuba Embargo With New Measures
The Obama administration is loosening the US trade embargo on Cuba with a new round of regulations allowing American companies to sell to Cuba on credit and export a potentially wide range of products to the Cuban government for the first time, officials said yesterday.
-
US Regulator Issues Import Alert on Aarti Drugs' 2 Plants
Aarti Drugs on Tuesday said its two manufacturing facilities have received import alert from the US Food and Drug Administration, a development which could impact the company's exports to the American market.
-
US Regulator Raises Concerns on Waluj Plant: Wockhardt
Shares in Wockhardt Ltd fell as much as 5.3 per cent on Thursday after the drug maker said the US Food and Drug Administration (FDA) had raised fresh concerns about a plant already banned from exporting to the United States over quality issues.
-
Wockhardt Says US Drug Regulator Raises Concern Over US Unit
The FDA last year banned Wockhardt's two Indian units from exporting to the United States, its biggest market, citing quality lapses in the manufacturing process.
-
Pharma Exports to US to Remain Unaffected by Import Alerts: India Ratings
Indian pharmaceutical exports to the US are expected to keep growing despite a spate of import alerts issued by the American drug regulator in 2013, according to a report by India Ratings & Research.
-
India Acts to Repair Reputation as Drugs Exporter
As part of the charm offensive, New Delhi has invited global regulators - including the FDA - to visit Indian production units to get first-hand evidence of measures taken to ensure the quality of locally manufactured generics.
-
Ranbaxy shares slump; US regulator raises concerns about India plants
All of Ranbaxy's India-based factories are currently banned by the FDA from exporting medicines to the United States, the company's largest market, after the regulator's inspection found violation of its so-called good manufacturing practices.
